Published: Nov 03, 2021
SHENZHEN, China, Nov. 3, 2021 /PRNewswire/ -- As reported by Indonesian National Agency of Drug and Food Control (BPOM), BPOM grants the Emergency Use Authorization (EUA) for COVID-19 Vaccine (ChAdOx1-S[recombinant])/KconecaVac manufactured by Shenzhen Kangtai Biological Products Co., Ltd.. It is understood that this is China's second adenovirus vector COVID-19 vaccine approved for emergency use overseas.
BPOM source: http://cekbpom.pom.go.id//home/produk/ia50q76n48d7ou9ibfgcn3rik7/all/row/10/page/1/order/4/DESC/search/0/EUA
SOURCE Shenzhen Kangtai Biological Products Co., Ltd.
Company Codes: Shenzhen: 300601
China, Malaysia companies inks deal on clinical trial, commercialization of COVID-19 vaccines
COVID-19: A Basic Guide to Different Vaccine Types and How They Work
With global push for COVID-19 vaccines, China aims to win friends and cut deals